More On

Glaxo agrees to pay $3 billion to settle marketing probes

Agreement will be largest pharmaceutical marketing settlement in U.S. history

Today GlaxoSmithKline (GSK), the U.K.’s biggest drug company, announced that it has agreed to pay the U.S. government $3 billion to settle several criminal and civil probes related to its sales and marketing practices. The agreement, which the company expects to finalize over the next year, will be the largest pharmaceutical marketing settlement in U.S. history.

The Wall Street Journal reports that GSK’s settlement will resolve prolonged investigations of whether it illegally marketed some of its top-selling drugs, including Avandia, Paxil and Wellbutrin, and defrauded Medicaid.

Ashley Post

Bio and more articles

Join the Conversation

Advertisement. Closing in 15 seconds.